Jonathan Schechter

Jonathan Schechter is a declared insider at 3 companies (board member); the most frequent names are TAO Synergies Inc., TaoWeave, Inc. and PharmaCyte Biotech, Inc. We count 8 filings; the first trade dates from 13 July 2021 and the latest from 5 January 2026.

The open-market side counts 4 purchases for €64k alongside 1 sale for €22k. Netting one side against the other leaves €42k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. So far in 2026, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €15k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 7 January 2026, the filings show an open-market purchase worth €13k in PharmaCyte Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.